12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several healthcare stocks showed significant movement. Biolase, Terns Pharma, Aptevo Therapeutics, Nexalin Technology, Evolus, and Phio Pharma were among the gainers, with Biolase leading by a 20% increase following their Q4 earnings release. On the downside, Cutera, Hyperfine, China SXT Pharmaceuticals, Vicarious Surgical, Meihua Intl Medical Techs, and Assure Holdings experienced declines, with Cutera dropping 11.7% after their Q4 earnings announcement.
March 21, 2024 | 9:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biolase stock rose 20% to $0.18 after announcing Q4 earnings, with a market value of $3.4 million.
The significant rise in Biolase's stock price is directly attributed to the positive reception of their Q4 earnings report. Given the substantial percentage increase, this news is highly relevant and important to investors.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Cutera stock decreased by 11.7% to $2.03 after their Q4 earnings were announced, with a market cap of $40.5 million.
Cutera's stock price decline is directly linked to its Q4 earnings release. The negative market reaction suggests the earnings did not meet investor expectations, making this news highly relevant and impactful.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Hyperfine stock declined by 7.97% to $1.04, with a market cap of $74.4 million, following their Q4 earnings announcement.
Hyperfine's stock decline is a direct consequence of its Q4 earnings announcement. The negative investor response indicates the results were below expectations, making this news highly relevant and impactful.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100